Latest Tetrabenazine Stories
-- PDE10 Inhibitor Administered to Patients with Huntington's Disease -- SEATTLE, Feb.
No drug has been shown to improve the loss of the ability to move muscles voluntarily, until now. A new drug called pridopidine stabilizes dopamine signaling in areas of the brain that control movement and coordination.
Results achieved over 80 weeks of treatment consistent with statistically significant reduction in chorea demonstrated in pivotal study.
NEW YORK, Oct.
DURHAM, N.C., Jan. 13 /PRNewswire/ -- S&R Communications Group has entered a strategic partnership with Ovation Pharmaceuticals, Inc., to launch Xenazine* (tetrabenazine), a treatment for chorea associated with Huntington's disease (HD).
DUBLIN and NEWCASTLE, England, December 8 /PRNewswire/ -- - Marketing Partner UCB Expects to Receive Completed Price and Reimbursement Approval for Tetrabenazine in H1 2009 - Exclusive Distribution Rights Granted in Finland (MediFront) and Taiwan (Giddi Pharma); Distribution Contracts Renewed in Australia and New Zealand Cambridge Laboratories Limited ("Cambridge" or "the Company"), the privately-owned specialty pharmaceutical company, today announces that its flagship product...
By Rita Rubin Baylor College of Medicine neurologist Joseph Jankovic is a patient man. With the Food and Drug Administration's OK, Jankovic has studied the drug tetrabenazine since 1979.
- A serpent whose bite was fabled to produce intense thirst.